Načítá se...
What are the pros and cons of the use of host-targeted agents against hepatitis C?
Hepatitis C virus (HCV) therapy is living a revolution. Host-targeted agents (HTAs) block HCV production by interacting with host cell components. Because they target conserved host proteins, not variable viral proteins, HTAs have the potential for pangenotypic antiviral activity and a high barrier...
Uloženo v:
| Vydáno v: | Antiviral Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier B.V.
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7173253/ https://ncbi.nlm.nih.gov/pubmed/24583032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2014.02.008 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|